Publications by authors named "Bannwarth S"

The identification of a point mutation (p.Ser59Leu) in the CHCHD10 gene was the first genetic evidence that mitochondrial dysfunction can trigger motor neuron disease. Since then, we have shown that this mutation leads to the disorganization of the MItochondrial contact site and Cristae Organizing System (MICOS) complex that maintains the mitochondrial cristae structure.

View Article and Find Full Text PDF

Objective: The objective of this study was to evaluate the implementation of NGS within the French mitochondrial network, MitoDiag, from targeted gene panels to whole exome sequencing (WES) or whole genome sequencing (WGS) focusing on mitochondrial nuclear-encoded genes.

Methods: Over 2000 patients suspected of Primary Mitochondrial Diseases (PMD) were sequenced by either targeted gene panels, WES or WGS within MitoDiag. We described the clinical, biochemical, and molecular data of 397 genetically confirmed patients, comprising 294 children and 103 adults, carrying pathogenic or likely pathogenic variants in nuclear-encoded genes.

View Article and Find Full Text PDF

Three-dimensional body scanners are attracting increasing interest in various application areas. To evaluate their accuracy, their 3D point clouds must be compared to a reference system by using a reference object. Since different scanning systems use different coordinate systems, an alignment is required for their evaluation.

View Article and Find Full Text PDF

Biallelic rare variants in NARS2 that encode the mitochondrial asparaginyl-tRNA synthetase are associated with a wide spectrum of clinical phenotypes ranging from severe neurodegenerative disorders to isolated mitochondrial myopathy or deafness. To date, only a small number of patients with NARS2 variants have been reported, and possible genotype-phenotype correlations are still lacking. Here, we present three siblings who had an early-onset hearing loss, while one developed severe symptoms in adulthood associated with early intellectual impairment, refractory seizures, moderate axonal sensorimotor neuropathy, and atypical psychiatric symptoms.

View Article and Find Full Text PDF
Article Synopsis
  • Advances in omics technologies are enhancing the diagnosis of rare diseases by developing methods to identify responsible genes, particularly using transcriptomic data for detecting aberrant gene expression (AGE).
  • ABEILLE is a new method that uses variational autoencoders and decision trees to identify AGEs in RNA-seq data without needing replicates or control groups, focusing on flexibility and severity of aberrations.
  • The source code for ABEILLE is available for free on GitHub, alongside supplementary data for further insights.
View Article and Find Full Text PDF

CHCHD10 is an amyotrophic lateral sclerosis/frontotemporal dementia gene that encodes a mitochondrial protein whose precise function is unclear. Here we show that Coiled-Coil-Helix-Coiled-Coil-Helix Domain Containing protein 10 interacts with the Stomatin-Like Protein 2 and participates in the stability of the prohibitin complex in the inner mitochondrial membrane. By using patient fibroblasts and mouse models expressing the same CHCHD10 variant (p.

View Article and Find Full Text PDF

Rare diseases (RDs) concern a broad range of disorders and can result from various origins. For a long time, the scientific community was unaware of RDs. Impressive progress has already been made for certain RDs; however, due to the lack of sufficient knowledge, many patients are not diagnosed.

View Article and Find Full Text PDF

Background: We tested the workflow and comparability of compression garments (CG) automatically knitted from 3D-body-scan data (3DBSD) versus manually measured data for scar treatment. Industry 4.0 has found its way into surgery, enhancing the trend toward personalized medicine, which plays an increasingly important role in CG scar therapy.

View Article and Find Full Text PDF

Purpose: Diseases caused by defects in mitochondrial DNA (mtDNA) maintenance machinery, leading to mtDNA deletions, form a specific group of disorders. However, mtDNA deletions also appear during aging, interfering with those resulting from mitochondrial disorders.

Methods: Here, using next-generation sequencing (NGS) data processed by eKLIPse and data mining, we established criteria distinguishing age-related mtDNA rearrangements from those due to mtDNA maintenance defects.

View Article and Find Full Text PDF
Article Synopsis
  • * There's a need for better understanding, management, and support for patients to improve their quality of life and reduce the economic impact of these diseases.
  • * The development of databases for patient data and technological innovations is crucial for enhancing diagnosis, treatment consensus, and the efficiency of clinical trials, alongside the formation of expert communities for collaboration.
View Article and Find Full Text PDF

Mutations in coiled-coil-helix-coiled-coil-helix domain containing 10 (CHCHD10) can cause amyotrophic lateral sclerosis and frontotemporal dementia (ALS-FTD). However, the underlying mechanisms are unclear. Here, we generate CHCH10-mutant Drosophila melanogaster and HeLa cell lines to model CHCHD10-associated ALS-FTD.

View Article and Find Full Text PDF

The molecular study of mitochondrial diseases, essential for diagnosis, is special due to the dual genetic origin of these pathologies: mitochondrial DNA and nuclear DNA. Complete mtDNA sequencing still remains the first line diagnostic test followed if negative, by resequencing panels of several hundred mitochondrially-encoded nuclear genes. This strategy, with an initial entire mtDNA sequencing, is currently justified by the presence of nuclear mitochondrial DNA sequences (NUMTs) in the nuclear genome.

View Article and Find Full Text PDF

Mitochondrial diseases (MD) are rare disorders caused by deficiency of the mitochondrial respiratory chain, which provides energy in each cell. They are characterized by a high clinical and genetic heterogeneity and in most patients, the responsible gene is unknown. Diagnosis is based on the identification of the causative gene that allows genetic counseling, prenatal diagnosis, understanding of pathological mechanisms, and personalized therapeutic approaches.

View Article and Find Full Text PDF
Article Synopsis
  • - Whole mitochondrial DNA sequencing is now routinely used in clinical labs to identify mitochondrial disease in patients, aided by Next Generation Sequencing, which has revealed many new mtDNA variants.
  • - Alongside an increase in identified pathogenic variants, there has also been a rise in variants of unknown significance (VUS), complicating their interpretation for patient treatment and counseling.
  • - The study characterized eight heteroplasmic mtDNA variants, classifying some as "definitely pathogenic," while others remain "possibly pathogenic," showcasing the importance of single fiber studies in diagnosing low-level heteroplasmy cases.
View Article and Find Full Text PDF

Objective: While the most frequent mutation responsible for mitochondrial diabetes is the point mutation m.3243 A>G of mitochondrial DNA (mtDNA), few data are available about the role of rare mtDNA mutations in the pathophysiology of diabetes. The main objective of our study was to describe the phenotypic characteristics of patients suffering from diabetes linked to rare mtDNA mutations.

View Article and Find Full Text PDF

Among mitochondrial diseases, isolated complex V (CV) deficiency represents a rare cause of respiratory chain (RC) dysfunction. In mammalian mitochondrial DNA (mtDNA), partly overlaps with making double mutations possible, yet extremely rarely reported principally in patients with cardiomyopathy. Here, we report a novel m.

View Article and Find Full Text PDF

Petite Integration Factor 1 (PIF1) is a multifunctional helicase present in nuclei and mitochondria. PIF1 knock out (KO) mice exhibit accelerated weight gain and decreased wheel running on a normal chow diet. In the current study, we investigated whether Pif1 ablation alters whole body metabolism in response to weight gain.

View Article and Find Full Text PDF

The genetic causes of Leigh syndrome are heterogeneous, with a poor genotype-phenotype correlation. To date, more than 50 nuclear genes cause nuclear gene-encoded Leigh syndrome. NDUFS6 encodes a 13 kiloDaltons subunit, which is part of the peripheral arm of complex I and is localized in the iron-sulfur fraction.

View Article and Find Full Text PDF
Article Synopsis
  • Recent research identified the CHCHD10 gene's role in mitochondrial dysfunction, linked to motor neuron degeneration, especially in conditions like ALS and frontotemporal dementia.
  • A study highlighted a specific mutation (p.Ser59Leu) in the CHCHD10 gene leading to symptoms in mice that resembled those seen in affected patients, primarily involving early-onset mitochondrial cardiomyopathy and motor neuron degeneration.
  • The study found that the mutation impairs cellular processes in muscle and motor neurons, showing sensitivity to stress and leading to significant deterioration before neurons are lost, indicating a gradual progression of disease pathology.
View Article and Find Full Text PDF

Purpose: Accurate detection of mitochondrial DNA (mtDNA) alterations is essential for the diagnosis of mitochondrial diseases. The development of high-throughput sequencing technologies has enhanced the detection sensitivity of mtDNA pathogenic variants, but the detection of mtDNA rearrangements, especially multiple deletions, is still poorly processed. Here, we present eKLIPse, a sensitive and specific tool allowing the detection and quantification of large mtDNA rearrangements from single and paired-end sequencing data.

View Article and Find Full Text PDF

We describe two patients with mitochondrial DNA mutations in the gene encoding cytochrome b (m.15579A>G, p.Tyr278Cys and m.

View Article and Find Full Text PDF

Following the involvement of CHCHD10 in FrontoTemporal-Dementia-Amyotrophic Lateral Sclerosis (FTD-ALS) clinical spectrum, a founder mutation (p.Gly66Val) in the same gene was identified in Finnish families with late-onset spinal motor neuronopathy (SMAJ). SMAJ is a slowly progressive form of spinal muscular atrophy with a life expectancy within normal range.

View Article and Find Full Text PDF